Lajos Pusztai

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 72

Top Topics

Locally Advanced

Circulating Tumor

Top Venues

NPJ breast cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alejandro Ríos-Hoyo, Erin Cobain, Laura A Huppert, Peter D Beitsch, Thomas A Buchholz, Laura Esserman, Laura J van 't Veer, Hope S Rugo, Lajos Pusztai
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Katia Khoury, Jane L Meisel, Christina Yau, Hope S Rugo, Rita Nanda, Marie Davidian, Butch Tsiatis, A Jo Chien, Anne M Wallace, Mili Arora, Mariya Rozenblit, Dawn L Hershman, Alexandra S Zimmer, Amy S Clark, Heather Beckwith, Anthony D Elias, Erica Stringer-Reasor, Judy C Boughey, Chaitali Nangia, Christos Vaklavas, Coral Omene, Kathy S Albain, Kevin M Kalinsky, Claudine Isaacs, Jennifer Tseng, Evanthia T Roussos Torres, Brittani Thomas, Alexandra Thomas, Amy Sanford, Ronald Balassanian, Cheryl Ewing, Kay Yeung, Candice A M Sauder, Tara Sanft, Lajos Pusztai, Meghna S Trivedi, Ashton Outhaythip, Wen Li, Natsuko Onishi, Adam L Asare, Philip Beineke, Peter Norwood, Lamorna Brown Swigart, Gillian L Hirst, Jeffrey B Matthews, Brian Moore, W Fraser Symmans, Elissa Price, Carolyn Beedle, Jane Perlmutter, Paula R Pohlmann, Rebecca A Shatsky, Angela M DeMichele, Douglas Yee, Laura van 't Veer, Nola M Hylton, Laura J Esserman
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nature medicine (2024)
Julia Foldi, Kim R M Blenman, Michał Marczyk, Vignesh Gunasekharan, Alicja Polanska, Renelle Gee, Mya Davis, Adriana M Kahn, Andrea Silber, Lajos Pusztai
Peripheral blood immune parameters, response, and adverse events after neoadjuvant chemotherapy plus durvalumab in early-stage triple-negative breast cancer. Breast cancer research and treatment (2024)
Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ciao-Sin Chen, Gary R Zirpoli, G Thomas Budd, William E Barlow, Lajos Pusztai, Gabriel N Hortobagyi, Kathy S Albain, Andrew K Godwin, Alastair Thompson, Norah L Henry, Christine B Ambrosone, Kathleen A Stringer, Daniel Louis Hertz
Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221. Cancer chemotherapy and pharmacology (2024)
Alejandro Ríos-Hoyo, Erin Cobain, Laura A Huppert, Peter D Beitsch, Thomas A Buchholz, Laura Esserman, Laura J van 't Veer, Hope S Rugo, Lajos Pusztai
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Matteo Dugo, Chiun-Sheng Huang, Daniel Egle, Begoña Bermejo, Claudio Zamagni, Robert S Seitz, Tyler J Nielsen, Marc Thill, Antonio Antón-Torres, Stefania Russo, Eva Ciruelos Gil, Brock L Schweitzer, Douglas Teller Ross, Barbara Galbardi, Richard Greil, Vladimir Semiglazov, Gyorffy Balazs, Marco Colleoni, Catherine M Kelly, Gabriella Mariani, Lucia Del Mastro, Olivia Blasi, Maurizio Callari, Lajos Pusztai, Pinuccia Valagussa, Giuseppe Viale, Luca Gianni, Giampaolo Bianchini
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Delaney V Rutherford, Sarah Medley, Nicholas C Henderson, Christina L Gersch, Ted A Vandenberg, Kathy S Albain, Shaker R Dakhil, Nagendra R Tirumali, Julie R Gralow, Gabriel N Hortobagyi, Lajos Pusztai, Rita S Mehta, Daniel F Hayes, Kelley M Kidwell, Norah L Henry, William E Barlow, James M Rae, Daniel Louis Hertz
Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226. Pharmacogenomics (2023)
Rachel Jaber Chehayeb, Adriana M Kahn, Lajos Pusztai
Treatment efficacy score: a better surrogate for arm-level survival differences in neoadjuvant breast cancer trials? Future oncology (London, England) (2023)
Luca Licata, Giulia Viale, Mario Giuliano, Curigliano Giuseppe, Mariana Chavez-MacGregor, Julia Foldi, Oluchi Oke, Joseph Collins, Lucia Del Mastro, Fabio Puglisi, Filippo Montemurro, Claudio Vernieri, Lorenzo Gerratana, Sara Giordano, Alessia Rognone, Lorenzo Sica, Oreste Davide Gentilini, Stefano Cascinu, Lajos Pusztai, Antonio Giordano, Carmen Criscitiello, Giampaolo Bianchini
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer. NPJ breast cancer 9 (1) (2023)
Afroditi Nanou, Jieling Miao, Frank A W Coumans, Emily M Dolce, Elizabeth Darga, William E Barlow, Jeffrey B Smerage, Costanza Paoletti, Andrew K Godwin, Lajos Pusztai, Priyanka Sharma, Alastair Thompson, Gabriel N Hortobagyi, Leon W M M Terstappen, Daniel F Hayes
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer. JCO precision oncology 7 (2023)
Curigliano Giuseppe, Rebecca Dent, Antonio Llombart-Cussac, Mark D Pegram, Lajos Pusztai, Nicholas C Turner, Giuseppe Viale
Incorporating clinicopathological and molecular risk prediction tools to improve outcomes in early HR+/HER2- breast cancer. NPJ breast cancer 9 (1) (2023)
Natalie Danziger, Ethan S Sokol, Ryon P Graf, Matthew C Hiemenz, Jake Maule, Vamsi Parimi, Carlo Palmieri, Lajos Pusztai, Jeffrey S Ross, Richard S P Huang
Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay. The oncologist (2023)
Adriana Matutino Kahn, Reza Golestani, Malini Harigopal, Lajos Pusztai
Intratumor spatial heterogeneity in programmed death-ligand 1 (PD-L1) protein expression in early-stage breast cancer. Breast cancer research and treatment (2023)
Christopher J Minteer, Kyra Thrush-Evensen, John T González, Peter Niimi, Mariya Rozenblit, Joel Rozowsky, Jason J Liu, Mor Frank, Thomas McCabe, Albert T Higgins-Chen, Erin Hofstatter, Lajos Pusztai, Kenneth B Beckman, Mark B Gerstein, Morgan E Levine
More than bad luck: Cancer and aging are linked to replication-driven changes to the epigenome. Science advances 9 (29) (2023)
Afroditi Nanou, Jieling Miao, Frank A W Coumans, Emily M Dolce, Elizabeth Darga, William E Barlow, Jeffrey B Smerage, Costanza Paoletti, Andrew K Godwin, Lajos Pusztai, Priyanka Sharma, Alastair Thompson, Gabriel N Hortobagyi, Leon W M M Terstappen, Daniel F Hayes
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer. JCO precision oncology 7 (2023)
Mattia Rediti, Aranzazu Fernandez-Martinez, David Venet, Françoise Rothé, Katherine A Hoadley, Joel S Parker, Baljit Singh, Jordan D Campbell, Karla V Ballman, David W Hillman, Eric P Winer, Sarra El-Abed, Martine J Piccart, Serena Di Cosimo, William Fraser Symmans, Ian E Krop, Roberto Salgado, Sherene Loi, Lajos Pusztai, Charles M Perou, Lisa Anne Carey, Christos Sotiriou
Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials. Nature communications 14 (1) (2023)
Lajos Pusztai, Mariya Rozenblit, Peter Dubsky, Thomas Bachelot, Anna M Kirby, Barbro K Linderholm, Julia R White, Steven J Chmura, Lisa Anne Carey, Boon H Chua, Kathy D Miller
De Novo Oligometastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Luca Licata, Marco Barreca, Barbara Galbardi, Matteo Dugo, Giulia Viale, Balàzs Győrffy, Thomas Karn, Lajos Pusztai, Luca Gianni, Maurizio Callari, Giampaolo Bianchini
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy. British journal of cancer (2023)
Lajos Pusztai
Systemic Staging of Locally Advanced Breast Cancer: How Hard to Look? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, David L Rimm, Gabriel N Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R M Blenman
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial. NPJ breast cancer 9 (1) (2023)
Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, David L Rimm, Gabriel N Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R M Blenman
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial. NPJ breast cancer 9 (1) (2023)
Curigliano Giuseppe, Rebecca Dent, Antonio Llombart-Cussac, Mark D Pegram, Lajos Pusztai, Nicholas C Turner, Giuseppe Viale
Incorporating clinicopathological and molecular risk prediction tools to improve outcomes in early HR+/HER2- breast cancer. NPJ breast cancer 9 (1) (2023)
Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, David L Rimm, Gabriel N Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R M Blenman
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial. NPJ breast cancer 9 (1) (2023)
Hao-Kuen Lin, Thuy Can, Adriana Kahn, Cynthia A Flannery, Jess Hoag, Alekhya Akkunuri, Helen Bailey, Rick Baehner, Lajos Pusztai, Mariya Rozenblit
Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay. The oncologist (2023)
Shane R Stecklein, William E Barlow, Lajos Pusztai, Kirsten Timms, Richard D Kennedy, Gemma E Logan, Robert S Seitz, Sunil S Badve, Yesim Gökmen-Polar, Peggy Porter, Hannah Linden, Debasish Tripathy, Gabriel N Hortobagyi, Andrew K Godwin, Alastair Thompson, Daniel F Hayes, Priyanka Sharma
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency. JCO precision oncology 7 (2023)
Corey W Speers, William Fraser Symmans, William E Barlow, Alexander J Trevarton, Stephanie The, Lili Du, James M Rae, Steven Shak, Frederick L Baehner, Priyanka Sharma, Lajos Pusztai, Gabriel N Hortobagyi, Daniel F Hayes, Kathy S Albain, Andrew K Godwin, Alastair Thompson
Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant trebananib plus paclitaxel-based chemotherapy for stage II/III breast cancer in the adaptively randomized I-SPY2 trial - Efficacy and biomarker discovery. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Afroditi Nanou, Jieling Miao, Frank A W Coumans, Emily M Dolce, Elizabeth Darga, William E Barlow, Jeffrey B Smerage, Costanza Paoletti, Andrew K Godwin, Lajos Pusztai, Priyanka Sharma, Alastair Thompson, Gabriel N Hortobagyi, Leon W M M Terstappen, Daniel F Hayes
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer. JCO precision oncology 7 (2023)
Curigliano Giuseppe, Rebecca Dent, Antonio Llombart-Cussac, Mark D Pegram, Lajos Pusztai, Nicholas C Turner, Giuseppe Viale
Incorporating clinicopathological and molecular risk prediction tools to improve outcomes in early HR+/HER2- breast cancer. NPJ breast cancer 9 (1) (2023)
Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, David L Rimm, Gabriel N Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R M Blenman
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial. NPJ breast cancer 9 (1) (2023)
Jennifer K Litton, Meredith M Regan, Lajos Pusztai, Hope S Rugo, Sara M Tolaney, Elizabeth Garrett-Mayer, Laleh Amiri-Kordestani, Reva K Basho, Ana F Best, Jean-Francois Boileau, Carsten Denkert, Jared C Foster, Nadia Harbeck, Heather A Jacene, Tari A King, Ginny Mason, Ciara Catherine O'Sullivan, Tatiana M Prowell, Andrea L Richardson, Karla A Sepulveda, Mary Lou Smith, Judy A Tjoe, Gulisa Turashvili, Wendy A Woodward, Lynn Pearson Butler, Elena I Schwartz, Larissa A Korde
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Afroditi Nanou, Jieling Miao, Frank A W Coumans, Emily M Dolce, Elizabeth Darga, William E Barlow, Jeffrey B Smerage, Costanza Paoletti, Andrew K Godwin, Lajos Pusztai, Priyanka Sharma, Alastair Thompson, Gabriel N Hortobagyi, Leon W M M Terstappen, Daniel F Hayes
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer. JCO precision oncology 7 (2023)
Afroditi Nanou, Jieling Miao, Frank A W Coumans, Emily M Dolce, Elizabeth Darga, William E Barlow, Jeffrey B Smerage, Costanza Paoletti, Andrew K Godwin, Lajos Pusztai, Priyanka Sharma, Alastair Thompson, Gabriel N Hortobagyi, Leon W M M Terstappen, Daniel F Hayes
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer. JCO precision oncology 7 (2023)
Julia Foldi, Adriana M Kahn, Andrea L M Silber, Tao Qing, Emily Reisenbichler, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Anees Chagpar, Tristen Park, Adam Blanchard, Kim R M Blenman, David L Rimm, Lajos Pusztai
Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Iván Pérez-Núñez, Catalina Rozalén, José Ángel Palomeque, Irene Sangrador, Mariona Dalmau, Laura Comerma, Anna Hernández-Prat, David Casadevall, Silvia Menendez, Daniel Dan Liu, Minhong Shen, Jordi Berenguer, Irene Rius Ruiz, Raul Peña, José Carlos Montañés, M Mar Albà, Sarah Bonnin, Julia Ponomarenko, Roger R Gomis, Juan Miguel Cejalvo, Sonia Servitja, Diego M Marzese, Lluis Morey, Leonie Voorwerk, Joaquín Arribas, Begoña Bermejo, Marleen Kok, Lajos Pusztai, Yibin Kang, Joan Albanell, Toni Celià-Terrassa
LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer. Nature cancer 3 (3) (2022)
Michał Marczyk, Vignesh Gunasekharan, David Casadevall, Tao Qing, Julia Foldi, Raghav Sehgal, Naing Lin Shan, Kim R M Blenman, Tess A O'Meara, Sheila Umlauf, Yulia V Surovtseva, Viswanathan Muthusamy, Jesse Rinehart, Rachel J Perry, Richard Kibbey, Christos Hatzis, Lajos Pusztai
Comprehensive Analysis of Metabolic Isozyme Targets in Cancer. Cancer research 82 (9) (2022)
Julia Foldi, Andrea Silber, Emily S Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Chagpar, Tristen Park, Michał Marczyk, Courtney Frederick, Trisha Burrello, Eiman Y Ibrahim, Tao Qing, Yalai Bai, Kim Blenman, David L Rimm, Lajos Pusztai
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer. NPJ breast cancer 8 (1) (2022)
Meiling Zhang, Zongzhi Z Liu, Keisuke Aoshima, Wesley L Cai, Hongyin Sun, Tianrui Xu, Yangyi Zhang, Yongyan An, Jocelyn F Chen, Lok Hei Chan, Asako Aoshima, Sabine M Lang, Zhen-Wei Tang, Xuanlin Che, Yao Li, Sara J Rutter, Veerle Bossuyt, Xiang Chen, Jon S Morrow, Lajos Pusztai, David L Rimm, Mingzhu Yin, Qin Yan
CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression. Science translational medicine 14 (630) (2022)
Fabrice Andre, Nofisat Ismaila, Kimberly H Allison, William E Barlow, Deborah E Collyar, Senthil Damodaran, Norah L Henry, Komal Jhaveri, Kevin Kalinsky, Nicole M Kuderer, Anya Litvak, Erica L Mayer, Lajos Pusztai, Rachel Raab, Antonio C Wolff, Vered Stearns
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (16) (2022)
Tao Qing, Thomas Karn, Mariya Rozenblit, Julia Foldi, Michał Marczyk, Naing Lin Shan, Kim R M Blenman, Uwe Holtrich, Kevin M Kalinsky, Funda Meric-Bernstam, Lajos Pusztai
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers. NPJ breast cancer 8 (1) (2022)
Tao Qing, Hussein Mohsen, Vincent L Cannataro, Michał Marczyk, Mariya Rozenblit, Julia Foldi, Michael Murray, Jeffrey P Townsend, Yuval Kluger, Mark Gerstein, Lajos Pusztai
Cancer Relevance of Human Genes. Journal of the National Cancer Institute 114 (7) (2022)
Kim R M Blenman, Michał Marczyk, Thomas Karn, Tao Qing, Xiaotong Li, Vignesh Gunasekharan, Vesal Yaghoobi, Yalai Bai, Eiman Y Ibrahim, Tristen Park, Andrea L M Silber, Denise M Wolf, Emily Reisenbichler, Carsten Denkert, Bruno Valentin Sinn, Mariya Rozenblit, Julia Foldi, David L Rimm, Sibylle Loibl, Lajos Pusztai
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Michal Marczyk, Tao Qing, Tess O'Meara, Vesal Yagahoobi, Vasiliki Pelekanou, Yalai Bai, Emily S Reisenbichler, Kimberly S Cole, Xiaotong Li, Vignesh Gunasekharan, Eiman Ibrahim, Kristina A Fanucci, Wei Wei, David L Rimm, Lajos Pusztai, Kim R M Blenman
Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer. NPJ breast cancer 8 (1) (2022)
Pashtoon Murtaza Kasi, Gordon Fehringer, Hiroya Taniguchi, Naureen Starling, Yoshiaki Nakamura, Daisuke Kotani, Thomas Powles, Bob T Li, Lajos Pusztai, Vasily N Aushev, Ekaterina Kalashnikova, Shruti Sharma, Meenakshi Malhotra, Zachary P Demko, Alexey Aleshin, Angel A Rodriguez, Paul R Billings, Axel Grothey, Gilles Manceau, David Cunningham, Takayuki Yoshino, Scott Kopetz
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors. JCO precision oncology 6 (2022)
Christina M Dieli-Cornwright, Maura Harrigan, Brenda Cartmel, Anees Chagpar, Yalai Bai, Fang-Yong Li, David L Rimm, Lajos Pusztai, Changquan Ling, Tara Sanft, Melinda L Irwin
Impact of a randomized weight loss trial on breast tissue markers in breast cancer survivors. NPJ breast cancer 8 (1) (2022)
Naing Lin Shan, Adriana Kahn, Lajos Pusztai
Intratumour heterogeneity, from hypothesis to the clinic. British journal of cancer (2022)
Francesco Schettini, Mario Giuliano, Fabiola Giudici, Benedetta Conte, Pietro De Placido, Sergio Venturini, Carla Rognoni, Angelo Di Leo, Mariavittoria Locci, Guy Jerusalem, Lucia Del Mastro, Fabio Puglisi, PierFranco Conte, Michelino De Laurentiis, Lajos Pusztai, Mothaffar F Rimawi, Rachel Schiff, Grazia Arpino, Sabino De Placido, Aleix Prat, Daniele Generali
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis. Cancers 13 (6) (2021)
Paula I Gonzalez Ericsson, Julia D Wulfkhule, Rosa I Gallagher, Xiaopeng Sun, Margaret L Axelrod, Quanhu Shen, Na Luo, Henry L Gómez, Violeta Sanchez, Melinda E Sanders, Lajos Pusztai, Emanuel Petricoin, Kim R M Blenman, Justin M Balko, null null
Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti-PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Ioannis A Vathiotis, Myrto K Moutafi, Prajan Divakar, Thazin Nwe Aung, Tao Qing, Aileen Fernandez, Vesal Yaghoobi, Sarra El-Abed, Yingbo Wang, Sebastien Guillaume, Paolo G Nuciforo, Jens Huober, Serena Di Cosimo, Sung-Bae Kim, Nadia Harbeck, Henry L Gómez, Saba Shafi, Konstantinos N Syrigos, George Fountzilas, Christos Sotiriou, Lajos Pusztai, Sarah Warren, David L Rimm
Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (22) (2021)
Tao Qing, Xinfeng Wang, Tomi Jun, Li Ding, Lajos Pusztai, Kuan-Lin Huang
Genomic Determinants of Homologous Recombination Deficiency across Human Cancers. Cancers 13 (18) (2021)
Toshiaki Iwase, Kim R M Blenman, Xiaotong Li, Emily Reisenbichler, Robert Seitz, David Hout, Tyler J Nielsen, Brock L Schweitzer, Daniel B Bailey, Yichao Shen, Xiang Zhang, Lajos Pusztai, Naoto Tada Ueno
A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer. Cancers 13 (19) (2021)
Halle C F Moore, William E Barlow, George Somlo, Julie R Gralow, Anne F Schott, Daniel F Hayes, Peter Kuhn, James B Hicks, Lisa Welter, Philip A Dy, Christina H Yeon, Alison K Conlin, Ernie Balcueva, Danika L Lew, Debasish Tripathy, Lajos Pusztai, Gabriel N Hortobagyi
A randomized trial of fulvestrant, everolimus and anastrozole for the front-line treatment of patients with advanced hormone receptor-positive breast cancer, SWOG S1222. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Gauri A Patwardhan, Michał Marczyk, Vikram B Wali, David F Stern, Lajos Pusztai, Christos Hatzis
Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations. NPJ breast cancer 7 (1) (2021)
David Venet, Mattia Rediti, Marion Maetens, Debora Fumagalli, David N Brown, Samira Majjaj, Roberto Salgado, Lajos Pusztai, Nadia Harbeck, Sarra El-Abed, Yingbo Wang, Cristina Saura, Henry L Gómez, Vladimir Fedorovich Semiglazov, Evandro de Azambuja, Jens Huober, Paolo G Nuciforo, Serena Di Cosimo, Martine Piccart, Sherene Loi, Françoise Rothé, Christos Sotiriou
Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (20) (2021)
Costanza Paoletti, William E Barlow, Erin F Cobain, Mattias Bergqvist, Rita S Mehta, Julie R Gralow, Gabriel N Hortobagyi, Kathy S Albain, Lajos Pusztai, Priyanka Sharma, Andrew K Godwin, Alastair M Thompson, Daniel F Hayes, James M Rae
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (22) (2021)
Helga Bergholtz, Jodi M Carter, Alessandra Cesano, Maggie Chon U Cheang, Sarah E Church, Prajan Divakar, Christopher A Fuhrman, Shom Goel, Jingjing Gong, Jennifer L Guerriero, Margaret L Hoang, E Shelley Hwang, Hellen Kuasne, Jinho Lee, Yan Liang, Elizabeth A Mittendorf, Jessica Perez, Aleix Prat, Lajos Pusztai, Jason W Reeves, Yasser Riazalhosseini, Jennifer K Richer, Özgür Sahin, Hiromi Sato, Ilana Schlam, Therese Sørlie, Daniel G Stover, Sandra M Swain, Alexander Swarbrick, E Aubrey Thompson, Sara M Tolaney, Sarah E Warren, null On Behalf Of The GeoMx Breast Cancer Consortium
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler. Cancers 13 (17) (2021)
Julia Foldi, Andrea Silber, Emily S Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Chagpar, Tristen Park, Michał Marczyk, Courtney Frederick, Trisha Burrello, Eiman Y Ibrahim, Tao Qing, Yalai Bai, Kim Blenman, David L Rimm, Lajos Pusztai
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer. NPJ breast cancer 7 (1) (2021)
Julia Foldi, Mariya Rozenblit, Tristen S Park, Christin A Knowlton, Mehra Golshan, Meena Moran, Lajos Pusztai
Optimal Management for Residual Disease Following Neoadjuvant Systemic Therapy. Current treatment options in oncology 22 (9) (2021)
Douglas Yee, Claudine Isaacs, Denise M Wolf, Christina Yau, Paul Haluska, Karthik V Giridhar, Andres Forero-Torres, A Jo Chien, Anne M Wallace, Lajos Pusztai, Kathy S Albain, Erin D Ellis, Heather Beckwith, Barbara B Haley, Anthony D Elias, Judy C Boughey, Kathleen Kemmer, Rachel L Yung, Paula R Pohlmann, Debasish Tripathy, Amy S Clark, Hyo S Han, Rita Nanda, Qamar J Khan, Kristen K Edmiston, Emanuel F Petricoin, Erica Stringer-Reasor, Carla I Falkson, Melanie Majure, Rita A Mukhtar, Teresa L Helsten, Stacy L Moulder, Patricia A Robinson, Julia D Wulfkuhle, Lamorna Brown Swigart, Meredith Buxton, Julia L Clennell, Melissa Paoloni, Ashish Sanil, Scott Berry, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Adam L Asare, Jeffrey B Matthews, Nola M Hylton, Angela M DeMichele, Michelle Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Donald A Berry, Laura J Esserman
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer. NPJ breast cancer 7 (1) (2021)
Fahad Shabbir Ahmed, Patricia Gaule, John McGuire, Katir Patel, Kim R M Blenman, Lajos Pusztai, David L Rimm
PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Tao Qing, Hussein Mohsen, Michał Marczyk, Yixuan Ye, Tess O'Meara, Hongyu Zhao, Jeffrey P Townsend, Mark Gerstein, Christos Hatzis, Yuval Kluger, Lajos Pusztai
Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden. Nature communications 11 (1) (2020)
Tess O'Meara, Anton Safonov, David Casadevall, Tao Qing, Andrea Silber, Brigid Killelea, Christos Hatzis, Lajos Pusztai
Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women. Breast cancer research and treatment 175 (1) (2019)
Amelia A Trant, Borbala Szekely, Sarah S Mougalian, Michael P DiGiovanna, Tara Sanft, Erin Hofstatter, Andrea Silber, Kerin B Adelson, Anees Chagpar, Brigid Killelea, Nina Horowitz, Donald Lannin, Tristen Park, Michelle Corso, Gineesha Abraham, Karen Pollard-Murphy, Tracy Sturrock, Elspeth Knill-Selby, Ashley Western, Camille Servodidio, Marios Konstantinos Tasoulis, Barbara Healy, Christos Hatzis, Lajos Pusztai
The impact of communication style on patient satisfaction. Breast cancer research and treatment 176 (2) (2019)